Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns

Study 126 cards on 30 common drug classes: mechanisms, qualified generic-name patterns, common uses, and major safety concepts for nursing and introductory health science.

Sobre este baralho

Build a durable pharmacology map with 126 independently authored cards. Six prerequisites define drug classes, mechanisms, agonism, antagonism, inhibition, and how to treat generic-name stems as fallible clues. The remaining 120 cards cover 30 common classes through four separate retrieval directions: class → core mechanism; qualified pattern or representative generics → class; class → common use; and class → major safety concept.

The deck deliberately excludes dosing, prescribing, patient-specific guidance, administration or hold parameters, exhaustive contraindications and interactions, monitoring protocols, brand names, official questions, and clinical cases. Generic-name patterns are clues, never universal rules. Use this deck for study—not clinical decision-making.

Ordering supports learning: prerequisites come first, then five spiral blocks mix six broad topic groups. Same-class variants stay at least three unrelated cards apart, alternating mechanism, recognition, common-use, and safety recall instead of forming predictable runs.

Open Study Contributor independently authored this standalone deck from common pharmacology knowledge checked against WHO, FDA, and NIH/NCBI sources. Organization names identify sources only; no affiliation or endorsement is claimed.

Cartões deste baralho

  1. Cartão 1

    Pergunta

    What is a drug class?

    Resposta

    A group of drugs linked by a shared mechanism, target, structure, therapeutic use, or a combination of these features.

  2. Cartão 2

    Pergunta

    What does mechanism of action mean?

    Resposta

    How a drug produces its effects at a molecular, cellular, or physiological target.

  3. Cartão 3

    Pergunta

    What is a receptor agonist?

    Resposta

    A drug that binds to a receptor and activates it to produce a response.

  4. Cartão 4

    Pergunta

    What is a receptor antagonist?

    Resposta

    A drug that binds to a receptor and blocks or reduces activation by an agonist.

  5. Cartão 5

    Pergunta

    What does it mean when a drug inhibits an enzyme or transporter?

    Resposta

    It reduces that protein's activity, changing the movement or conversion of its usual substrates.

  6. Cartão 6

    Pergunta

    How should generic-name stems be used to recognize drug classes?

    Resposta

    As clues, not universal rules. Confirm the actual drug because exceptions and overlapping stems exist.

  7. Cartão 7

    Pergunta

    ACE inhibitors: core mechanism?

    Resposta

    They inhibit angiotensin-converting enzyme, reducing angiotensin II and aldosterone while increasing bradykinin.

  8. Cartão 8

    Pergunta

    SSRIs: core mechanism?

    Resposta

    They inhibit the serotonin transporter, increasing serotonin signaling in the synaptic cleft.

  9. Cartão 9

    Pergunta

    Biguanides: core mechanism?

    Resposta

    Metformin mainly reduces hepatic glucose production and improves insulin sensitivity without directly stimulating insulin release.

  10. Cartão 10

    Pergunta

    Penicillins: core mechanism?

    Resposta

    Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.

  11. Cartão 11

    Pergunta

    Which class is often suggested by the ending -pril?

    Resposta

    ACE inhibitors. Examples include lisinopril and enalapril, but a name stem is only a clue.

  12. Cartão 12

    Pergunta

    Proton-pump inhibitors: core mechanism?

    Resposta

    They inhibit the H+/K+ ATPase proton pump in gastric parietal cells, strongly reducing acid secretion.

  13. Cartão 13

    Pergunta

    SSRIs: common uses?

    Resposta

    Depression and several anxiety-related disorders; the approved indications differ by agent.

  14. Cartão 14

    Pergunta

    NSAIDs: core mechanism?

    Resposta

    They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis.

  15. Cartão 15

    Pergunta

    Biguanides: major safety concepts?

    Resposta

    Gastrointestinal effects are common; vitamin B12 can fall with long use, and lactic acidosis is rare but serious.

  16. Cartão 16

    Pergunta

    Which class is often suggested by the ending -cillin?

    Resposta

    Penicillins, such as amoxicillin and piperacillin. The stem does not describe spectrum or resistance.

  17. Cartão 17

    Pergunta

    ACE inhibitors: common uses?

    Resposta

    Hypertension and selected heart-failure, post-myocardial-infarction, and kidney-protection indications.

  18. Cartão 18

    Pergunta

    Proton-pump inhibitors: major safety concepts?

    Resposta

    Possible concerns include hypomagnesemia and enteric infection risk. Many other long-term links are observational rather than proven causal effects.

  19. Cartão 19

    Pergunta

    Which class is often suggested by -oxetine or -opram?

    Resposta

    SSRIs, but not universally. Sertraline and fluvoxamine are exceptions, and some stems overlap other classes.

  20. Cartão 20

    Pergunta

    NSAIDs: common uses?

    Resposta

    Pain, inflammation, and fever; individual agents also have more specific uses.

  21. Cartão 21

    Pergunta

    Metformin belongs to which drug class?

    Resposta

    Biguanides. Metformin is the main widely used member, so there is no useful class-wide suffix rule.

  22. Cartão 22

    Pergunta

    Penicillins: major safety concepts?

    Resposta

    Hypersensitivity can range from rash to anaphylaxis; diarrhea and antibiotic-associated colitis are additional concerns.

  23. Cartão 23

    Pergunta

    ACE inhibitors: major safety concepts?

    Resposta

    Cough, hyperkalemia, kidney-function changes, angioedema, and fetal harm are major class concerns.

  24. Cartão 24

    Pergunta

    Proton-pump inhibitors: common uses?

    Resposta

    Acid-related disorders such as GERD, erosive esophagitis, and peptic-ulcer disease.

  25. Cartão 25

    Pergunta

    SSRIs: major safety concepts?

    Resposta

    Serotonin syndrome, bleeding and hyponatremia risks, sexual dysfunction, and the antidepressant suicidality warning for younger people.

  26. Cartão 26

    Pergunta

    Ibuprofen, naproxen, and ketorolac belong to which class?

    Resposta

    NSAIDs. The class has no single reliable generic-name suffix.

  27. Cartão 27

    Pergunta

    Biguanides: common use?

    Resposta

    Type 2 diabetes.

  28. Cartão 28

    Pergunta

    Penicillins: common use?

    Resposta

    Treatment of susceptible bacterial infections; the spectrum differs substantially among individual penicillins.

  29. Cartão 29

    Pergunta

    Which class is often suggested by the ending -prazole?

    Resposta

    Proton-pump inhibitors, such as omeprazole and pantoprazole. Confirm the individual drug.

  30. Cartão 30

    Pergunta

    NSAIDs: major safety concepts?

    Resposta

    Gastrointestinal bleeding, kidney injury, fluid retention, and cardiovascular events are key risks; FDA also warns about use from about 20 weeks of pregnancy.

  31. Cartão 31

    Pergunta

    Sulfonylureas: core mechanism?

    Resposta

    They close ATP-sensitive potassium channels in pancreatic beta cells, triggering insulin release even when glucose is not high.

  32. Cartão 32

    Pergunta

    H2 blockers: core mechanism?

    Resposta

    They competitively block histamine H2 receptors on gastric parietal cells, reducing acid secretion.

  33. Cartão 33

    Pergunta

    SNRIs: core mechanism?

    Resposta

    They inhibit serotonin and norepinephrine reuptake transporters, increasing both transmitters in synapses.

  34. Cartão 34

    Pergunta

    Opioid analgesics: core mechanism?

    Resposta

    They activate opioid receptors; many important analgesic effects and toxicities are mediated through mu receptors.

  35. Cartão 35

    Pergunta

    Glipizide, glyburide, and glimepiride belong to which class?

    Resposta

    Sulfonylureas. Their names offer clues, but the broad ending -ide is not class-specific.

  36. Cartão 36

    Pergunta

    ARBs: core mechanism?

    Resposta

    They block angiotensin II at AT1 receptors, reducing vasoconstriction and aldosterone effects.

  37. Cartão 37

    Pergunta

    H2 blockers: common uses?

    Resposta

    Acid-related disorders such as heartburn, GERD, and gastric or duodenal ulcers.

  38. Cartão 38

    Pergunta

    Cephalosporins: core mechanism?

    Resposta

    Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.

  39. Cartão 39

    Pergunta

    SNRIs: major safety concepts?

    Resposta

    Serotonin syndrome, blood-pressure increases, discontinuation symptoms, and the antidepressant suicidality warning for younger people.

  40. Cartão 40

    Pergunta

    Morphine, oxycodone, and fentanyl belong to which broad class?

    Resposta

    Opioid analgesics. The class has no single reliable generic-name suffix.

  41. Cartão 41

    Pergunta

    Sulfonylureas: common use?

    Resposta

    Type 2 diabetes when increasing pancreatic insulin release is appropriate.

  42. Cartão 42

    Pergunta

    ARBs: major safety concepts?

    Resposta

    Hyperkalemia, hypotension, kidney-function changes, and fetal harm are major concerns; cough is less common than with ACE inhibitors.

  43. Cartão 43

    Pergunta

    Which class is often suggested by the ending -tidine?

    Resposta

    H2 receptor blockers, such as famotidine and cimetidine. Confirm the individual drug.

  44. Cartão 44

    Pergunta

    Cephalosporins: common use?

    Resposta

    Treatment of susceptible bacterial infections; antibacterial spectrum varies widely by agent and generation.

  45. Cartão 45

    Pergunta

    Which name endings can suggest an SNRI?

    Resposta

    -faxine or sometimes -oxetine, but neither is decisive. The -oxetine ending also appears in some SSRIs.

  46. Cartão 46

    Pergunta

    Opioid analgesics: major safety concepts?

    Resposta

    Respiratory depression, sedation, constipation, tolerance, dependence, and overdose; benzodiazepines and other depressants increase danger.

  47. Cartão 47

    Pergunta

    Sulfonylureas: major safety concepts?

    Resposta

    Hypoglycemia and weight gain are the main class patterns, with risk differing among agents and clinical contexts.

  48. Cartão 48

    Pergunta

    ARBs: common uses?

    Resposta

    Hypertension and selected heart-failure and kidney-protection indications.

  49. Cartão 49

    Pergunta

    H2 blockers: major safety concepts?

    Resposta

    They are usually well tolerated, but confusion or other CNS effects can occur with reduced clearance; cimetidine has many interactions.

  50. Cartão 50

    Pergunta

    Which class is often suggested by cef- or ceph-?

    Resposta

    Cephalosporins, such as cefazolin and cephalexin. The name does not reveal the full spectrum.

  51. Cartão 51

    Pergunta

    SNRIs: common uses?

    Resposta

    Depression and anxiety disorders; selected agents also treat neuropathic pain or fibromyalgia.

  52. Cartão 52

    Pergunta

    Opioid analgesics: common uses?

    Resposta

    Analgesia for selected severe pain and perioperative settings; individual opioids also have other specific uses.

  53. Cartão 53

    Pergunta

    Which class is often suggested by the ending -sartan?

    Resposta

    Angiotensin II receptor blockers, or ARBs. Examples include losartan and valsartan.

  54. Cartão 54

    Pergunta

    Cephalosporins: major safety concepts?

    Resposta

    Hypersensitivity and antibiotic-associated diarrhea are important; penicillin cross-reactivity depends largely on similar side chains.

  55. Cartão 55

    Pergunta

    Beta2 agonists: core mechanism?

    Resposta

    They activate beta2 receptors, increasing cAMP and relaxing airway smooth muscle.

  56. Cartão 56

    Pergunta

    Beta blockers: core mechanism?

    Resposta

    They antagonize beta-adrenergic receptors; beta1 blockade can reduce heart rate, contractility, and renin release.

  57. Cartão 57

    Pergunta

    Systemic corticosteroids: core mechanism?

    Resposta

    They bind intracellular glucocorticoid receptors and alter gene transcription, reducing inflammatory and immune signaling.

  58. Cartão 58

    Pergunta

    Benzodiazepines: core mechanism?

    Resposta

    They positively modulate GABA-A receptors, increasing the frequency of chloride-channel opening when GABA is present.

  59. Cartão 59

    Pergunta

    Which class is often suggested by the ending -terol?

    Resposta

    Beta2 agonist bronchodilators, such as formoterol and salmeterol. Albuterol is a familiar exception.

  60. Cartão 60

    Pergunta

    Macrolides: core mechanism?

    Resposta

    They bind the bacterial 50S ribosomal subunit and inhibit protein synthesis.

  61. Cartão 61

    Pergunta

    Beta blockers: common uses?

    Resposta

    Selected cardiovascular conditions such as arrhythmias, ischemic heart disease, heart failure, and hypertension; some agents have noncardiac uses.

  62. Cartão 62

    Pergunta

    GLP-1 receptor agonists: core mechanism?

    Resposta

    They activate GLP-1 receptors, increasing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying.

  63. Cartão 63

    Pergunta

    Systemic corticosteroids: major safety concepts?

    Resposta

    Infection, hyperglycemia, osteoporosis, and hypothalamic-pituitary-adrenal suppression; risks rise with systemic exposure and duration.

    Abstract pharmacology study cover showing an unmarked capsule and tablet encircled by six colorful receptor, channel, enzyme, and signaling motifs on a navy field.

    126 cartões

    Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns

    Estude este baralho de graça

    O Nibomo abre para você começar a estudar.

  64. Cartão 64

    Pergunta

    Which endings often suggest a benzodiazepine?

    Resposta

    -azepam or -azolam, as in diazepam or midazolam. Not every sedative with a similar ending belongs to this class.

  65. Cartão 65

    Pergunta

    Beta2 agonists: common use?

    Resposta

    Bronchodilation in asthma or COPD regimens; short- and long-acting agents play different roles.

  66. Cartão 66

    Pergunta

    Macrolides: major safety concepts?

    Resposta

    Gastrointestinal effects, QT prolongation, and clinically important interactions that vary by agent.

  67. Cartão 67

    Pergunta

    Which class is often suggested by the ending -olol?

    Resposta

    Beta blockers, such as metoprolol and propranolol. Receptor selectivity still varies by agent.

  68. Cartão 68

    Pergunta

    GLP-1 receptor agonists: common uses?

    Resposta

    Type 2 diabetes; selected agents are also approved for chronic weight management and cardiovascular-risk reduction.

  69. Cartão 69

    Pergunta

    Which patterns often suggest a systemic corticosteroid?

    Resposta

    -sone or -olone, as in prednisone or prednisolone, but these endings are not unique to the class.

  70. Cartão 70

    Pergunta

    Benzodiazepines: major safety concepts?

    Resposta

    Sedation, dependence and withdrawal, plus respiratory depression—especially with opioids, alcohol, or other CNS depressants.

  71. Cartão 71

    Pergunta

    Beta2 agonists: major safety concepts?

    Resposta

    Tremor, palpitations or tachycardia, hypokalemia, and rare paradoxical bronchospasm.

  72. Cartão 72

    Pergunta

    Macrolides: common use?

    Resposta

    Treatment of selected susceptible bacterial infections, including some respiratory and atypical pathogens.

  73. Cartão 73

    Pergunta

    Beta blockers: major safety concepts?

    Resposta

    Bradycardia and hypotension; nonselective agents can cause bronchospasm, and the class can mask adrenergic signs of hypoglycemia.

  74. Cartão 74

    Pergunta

    Which class is often suggested by -glutide?

    Resposta

    GLP-1 receptor agonists, such as semaglutide and liraglutide. Exenatide and lixisenatide show the pattern is not universal.

  75. Cartão 75

    Pergunta

    Systemic corticosteroids: common uses?

    Resposta

    Inflammatory, allergic, and autoimmune disorders, with the route and agent chosen for the condition.

  76. Cartão 76

    Pergunta

    Benzodiazepines: common uses?

    Resposta

    Anxiety, seizures, procedural sedation, or alcohol withdrawal, depending on the agent and setting.

  77. Cartão 77

    Pergunta

    Which class is often suggested by the ending -thromycin?

    Resposta

    Macrolide antibiotics, such as azithromycin and clarithromycin. Confirm the individual agent.

  78. Cartão 78

    Pergunta

    GLP-1 receptor agonists: major safety concepts?

    Resposta

    Gastrointestinal effects are common; gallbladder disease and pancreatitis are warnings, and some labels warn about thyroid C-cell tumors.

  79. Cartão 79

    Pergunta

    Second-generation antipsychotics: core mechanism?

    Resposta

    Most modulate dopamine D2 and serotonin 5-HT2A signaling, but receptor profiles vary substantially by agent.

  80. Cartão 80

    Pergunta

    Tetracyclines: core mechanism?

    Resposta

    They bind the bacterial 30S ribosomal subunit and inhibit protein synthesis.

  81. Cartão 81

    Pergunta

    Dihydropyridine calcium-channel blockers: core mechanism?

    Resposta

    They block L-type calcium channels mainly in vascular smooth muscle, causing arteriolar relaxation.

  82. Cartão 82

    Pergunta

    Inhaled antimuscarinics: core mechanism?

    Resposta

    They block airway muscarinic receptors, reducing vagal bronchoconstriction and promoting bronchodilation.

  83. Cartão 83

    Pergunta

    Which endings often suggest a second-generation antipsychotic?

    Resposta

    -apine or -idone often appear, but many members use other endings and the stems are not class-specific.

  84. Cartão 84

    Pergunta

    SGLT2 inhibitors: core mechanism?

    Resposta

    They inhibit renal sodium-glucose cotransporter 2, increasing urinary glucose and sodium excretion.

  85. Cartão 85

    Pergunta

    Tetracyclines: common uses?

    Resposta

    Selected susceptible bacterial infections and, for some agents, acne or rosacea.

  86. Cartão 86

    Pergunta

    Bisphosphonates: core mechanism?

    Resposta

    They bind bone mineral and inhibit osteoclast-mediated bone resorption.

  87. Cartão 87

    Pergunta

    Dihydropyridine calcium-channel blockers: major safety concepts?

    Resposta

    Peripheral edema, flushing, headache, dizziness, and hypotension are characteristic patterns.

  88. Cartão 88

    Pergunta

    Which class is often suggested by the ending -tropium?

    Resposta

    Inhaled antimuscarinic bronchodilators, such as ipratropium and tiotropium. Several class members use other endings.

  89. Cartão 89

    Pergunta

    Second-generation antipsychotics: common uses?

    Resposta

    Schizophrenia and selected bipolar or other psychiatric indications; approvals differ by agent.

  90. Cartão 90

    Pergunta

    SGLT2 inhibitors: major safety concepts?

    Resposta

    Genital infections, volume depletion, ketoacidosis, and rare necrotizing infection of the perineum.

  91. Cartão 91

    Pergunta

    Which class is often suggested by the ending -cycline?

    Resposta

    Tetracycline antibiotics, such as doxycycline and minocycline. Confirm the individual drug.

  92. Cartão 92

    Pergunta

    Bisphosphonates: common uses?

    Resposta

    Osteoporosis and selected disorders with excessive bone resorption, including Paget disease or malignancy-related bone disease.

  93. Cartão 93

    Pergunta

    Which class is often suggested by the ending -dipine?

    Resposta

    Dihydropyridine calcium-channel blockers, such as amlodipine and nifedipine.

  94. Cartão 94

    Pergunta

    Inhaled antimuscarinics: major safety concepts?

    Resposta

    Dry mouth, urinary retention, tachycardia, and eye exposure that may worsen narrow-angle glaucoma.

  95. Cartão 95

    Pergunta

    Second-generation antipsychotics: major safety concepts?

    Resposta

    Metabolic effects, movement disorders, QT effects, and neuroleptic malignant syndrome; labels warn about increased mortality in elderly patients with dementia-related psychosis.

  96. Cartão 96

    Pergunta

    SGLT2 inhibitors: common uses?

    Resposta

    Type 2 diabetes; selected agents also treat heart failure or chronic kidney disease.

  97. Cartão 97

    Pergunta

    Tetracyclines: major safety concepts?

    Resposta

    Gastrointestinal or esophageal irritation, photosensitivity, and effects on developing teeth and bone are key patterns.

  98. Cartão 98

    Pergunta

    Which class is often suggested by the ending -dronate?

    Resposta

    Bisphosphonates, such as alendronate and risedronate. Confirm the individual agent and formulation.

  99. Cartão 99

    Pergunta

    Dihydropyridine calcium-channel blockers: common uses?

    Resposta

    Hypertension and angina, using vascular smooth-muscle relaxation to reduce arterial tone.

  100. Cartão 100

    Pergunta

    Inhaled antimuscarinics: common use?

    Resposta

    Maintenance bronchodilation, especially in COPD; selected agents also serve as add-on asthma therapy.

  101. Cartão 101

    Pergunta

    Which class is often suggested by the ending -gliflozin?

    Resposta

    SGLT2 inhibitors, such as empagliflozin and dapagliflozin.

  102. Cartão 102

    Pergunta

    Bisphosphonates: major safety concepts?

    Resposta

    Upper-GI irritation with oral agents, hypocalcemia, and rare osteonecrosis of the jaw or atypical femur fracture.

  103. Cartão 103

    Pergunta

    TNF inhibitors: core mechanism?

    Resposta

    They neutralize tumor necrosis factor signaling, reducing downstream inflammation.

  104. Cartão 104

    Pergunta

    DPP-4 inhibitors: core mechanism?

    Resposta

    They inhibit DPP-4, prolonging endogenous incretin activity and increasing glucose-dependent insulin release.

  105. Cartão 105

    Pergunta

    Inhaled corticosteroids: core mechanism?

    Resposta

    They activate glucocorticoid receptors in airway cells, reducing inflammatory gene expression and airway inflammation.

  106. Cartão 106

    Pergunta

    Statins: core mechanism?

    Resposta

    They inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing hepatic LDL-receptor activity.

  107. Cartão 107

    Pergunta

    Adalimumab, infliximab, and etanercept belong to which class?

    Resposta

    TNF inhibitors. The class has no single specific shared suffix: -mab is broad, and etanercept ends in -cept.

  108. Cartão 108

    Pergunta

    Triptans: core mechanism?

    Resposta

    They activate serotonin 5-HT1B/1D receptors, reducing trigeminal signaling and causing cranial vasoconstriction.

  109. Cartão 109

    Pergunta

    DPP-4 inhibitors: common use?

    Resposta

    Type 2 diabetes, using enhanced endogenous incretin signaling to improve glucose-dependent insulin release.

  110. Cartão 110

    Pergunta

    Fluoroquinolones: core mechanism?

    Resposta

    They inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication.

  111. Cartão 111

    Pergunta

    Inhaled corticosteroids: major safety concepts?

    Resposta

    Oral candidiasis and dysphonia are important local effects; systemic effects become more relevant with higher exposure.

  112. Cartão 112

    Pergunta

    Which class is suggested by the ending -statin?

    Resposta

    HMG-CoA reductase inhibitors, or statins, such as atorvastatin and rosuvastatin.

  113. Cartão 113

    Pergunta

    TNF inhibitors: common uses?

    Resposta

    Selected autoimmune inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis-related conditions.

  114. Cartão 114

    Pergunta

    Triptans: major safety concepts?

    Resposta

    Vasoconstrictive risk in coronary, cerebrovascular, or peripheral vascular disease, plus tingling, flushing, or chest pressure called triptan sensations.

  115. Cartão 115

    Pergunta

    Which class is suggested by the ending -gliptin?

    Resposta

    DPP-4 inhibitors, such as sitagliptin and linagliptin.

  116. Cartão 116

    Pergunta

    Fluoroquinolones: common use?

    Resposta

    Selected serious or resistant bacterial infections when their spectrum and risk profile fit the infection.

  117. Cartão 117

    Pergunta

    Which patterns often suggest an inhaled corticosteroid?

    Resposta

    -sonide or -sone often appear, as in budesonide or fluticasone, but these endings are not class-specific.

  118. Cartão 118

    Pergunta

    Statins: major safety concepts?

    Resposta

    Muscle symptoms and rare rhabdomyolysis or liver injury; pregnancy is a major risk context, although FDA no longer applies a blanket class contraindication.

  119. Cartão 119

    Pergunta

    TNF inhibitors: major safety concepts?

    Resposta

    Serious infections and reactivation of tuberculosis or hepatitis B are central concerns; other warnings vary by agent.

  120. Cartão 120

    Pergunta

    Triptans: common use?

    Resposta

    Acute treatment of migraine attacks; they are not general-purpose analgesics or routine migraine preventives.

  121. Cartão 121

    Pergunta

    DPP-4 inhibitors: major safety concepts?

    Resposta

    Severe joint pain and pancreatitis are warnings; some agents also carry a heart-failure warning.

  122. Cartão 122

    Pergunta

    Which class is suggested by the ending -floxacin?

    Resposta

    Fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin.

  123. Cartão 123

    Pergunta

    Inhaled corticosteroids: common use?

    Resposta

    Controller therapy for asthma and selected COPD regimens; they reduce inflammation rather than acting as standalone rescue bronchodilators.

  124. Cartão 124

    Pergunta

    Statins: common uses?

    Resposta

    Lowering LDL cholesterol and reducing atherosclerotic cardiovascular risk.

  125. Cartão 125

    Pergunta

    Which class is suggested by the ending -triptan?

    Resposta

    Triptan antimigraine agents, such as sumatriptan and rizatriptan.

  126. Cartão 126

    Pergunta

    Fluoroquinolones: major safety concepts?

    Resposta

    Potentially disabling tendon, muscle, joint, nerve, and CNS effects, plus a rare risk of aortic aneurysm or rupture in susceptible people.

Abstract pharmacology study cover showing an unmarked capsule and tablet encircled by six colorful receptor, channel, enzyme, and signaling motifs on a navy field.

126 cartões

Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns

Estude este baralho de graça

O Nibomo abre para você começar a estudar.